Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M155,957Revenue $M40,249Net Margin (%)24.5Altman Z-Score3.3
Enterprise Value $M171,329EPS $3.4Operating Margin %13.6Piotroski F-Score6
P/E(ttm)16.2Beneish M-Score-2.9Pre-tax Margin (%)38.5Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %5.4Quick Ratio1.3Cash flow > EarningsN
Price/Sales4.05-y EBITDA Growth Rate %4.0Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow27.7y-y EBITDA Growth Rate %58.1ROA % (ttm)9.7Higher Current Ratio y-yN
Dividend Yield %3.2PEG4.1ROE % (ttm)20.8Less Shares Outstanding y-yY
Payout Ratio %52.0Shares Outstanding M2,817ROIC % (ttm)6.4Gross Margin Increase y-yY

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKVanguard Health Care Fund 2015-06-30 Add0.65%$56.73 - $60.89
($58.76)
$ 55.37-6%Add 14.09%45,748,498
MRKCharles Brandes 2015-06-30 Add0.44%$56.73 - $60.89
($58.76)
$ 55.37-6%Add 26.81%2,817,473
MRKJoel Greenblatt 2015-06-30 Sold Out -0.3%$56.73 - $60.89
($58.76)
$ 55.37-6%Sold Out0
MRKKahn Brothers 2015-06-30 Reduce-0.13%$56.73 - $60.89
($58.76)
$ 55.37-6%Reduce 1.28%1,016,613
MRKJames Barrow 2015-06-30 Add0.09%$56.73 - $60.89
($58.76)
$ 55.37-6%Add 4.81%25,641,122
MRKDavid Dreman 2015-06-30 Buy 0.05%$56.73 - $60.89
($58.76)
$ 55.37-6%New holding11,463
MRKDodge & Cox 2015-06-30 Reduce-0.04%$56.73 - $60.89
($58.76)
$ 55.37-6%Reduce 3.02%24,680,781
MRKKen Fisher 2015-06-30 Add0.02%$56.73 - $60.89
($58.76)
$ 55.37-6%Add 2.35%6,836,547
MRKMario Gabelli 2015-06-30 Reduce$56.73 - $60.89
($58.76)
$ 55.37-6%Reduce 7.71%148,540
MRKNWQ Managers 2015-06-30 Reduce$56.73 - $60.89
($58.76)
$ 55.37-6%Reduce 3.27%73,790
MRKVanguard Health Care Fund 2015-03-31 Add0.53%$56.06 - $63.03
($59.34)
$ 55.37-7%Add 12.04%40,096,948
MRKDodge & Cox 2015-03-31 Reduce-0.44%$56.06 - $63.03
($59.34)
$ 55.37-7%Reduce 24.30%25,448,977
MRKKahn Brothers 2015-03-31 Reduce-0.22%$56.06 - $63.03
($59.34)
$ 55.37-7%Reduce 2.18%1,029,815
MRKJoel Greenblatt 2015-03-31 Reduce-0.17%$56.06 - $63.03
($59.34)
$ 55.37-7%Reduce 35.28%676,758
MRKJames Barrow 2015-03-31 Add0.13%$56.06 - $63.03
($59.34)
$ 55.37-7%Add 7.03%24,464,116
MRKCharles Brandes 2015-03-31 Reduce-0.07%$56.06 - $63.03
($59.34)
$ 55.37-7%Reduce 3.69%2,221,791
MRKNWQ Managers 2015-03-31 Reduce-0.01%$56.06 - $63.03
($59.34)
$ 55.37-7%Reduce 9.00%76,286
MRKMario Gabelli 2015-03-31 Add0.01%$56.06 - $63.03
($59.34)
$ 55.37-7%Add 11.45%160,943
MRKKen Fisher 2015-03-31 Add$56.06 - $63.03
($59.34)
$ 55.37-7%Add 0.59%6,679,499
MRKKahn Brothers 2014-12-31 Reduce-0.54%$53.43 - $61.88
($58.42)
$ 55.37-5%Reduce 5.08%1,052,807
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Golestani ClarkEVP & Chief Info Officer 2015-07-31Sell31,831$59.09-6.3view
Schechter Adam HEVP & Pres-Global Human Health 2015-05-11Sell10,634$60.44-8.39view
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy 2015-05-08Sell38,368$60.99-9.21view
Kuhlik Bruce NExe V-P & Gen Counsel 2015-05-04Sell56,064$60.2-8.02view
Holston Michael JEVP, Legal 2015-04-29Sell95,624$59.84-7.47view
Kuhlik Bruce NExe V-P & Gen Counsel 2015-04-29Sell156,902$59.82-7.44view
FRAZIER KENNETH CChairman, President & CEO 2015-02-18Sell5,164$58.67-5.62view
Deese Willie AExe V-P & Pres. MMD 2015-02-11Sell135,864$58.56-5.45view
WENDELL PETER CDirector 2015-02-09Sell5,000$58.76-5.77view
Schechter Adam HEVP & Pres-Global Human Health 2015-01-15Sell74,200$62.48-11.38view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

    News about MRK:

    Articles On GuruFocus.com
    Charles Brandes Beefs Up Second-Most Valuable Stake in Portfolio Aug 14 2015 
    Vanguard Health Care Fund Buys Two New Stakes in Second Quarter Aug 06 2015 
    Merck Reports Strong Second Quarter 2015 Earnings with Improved Outlook for the Full Year Jul 31 2015 
    Manning & Napier Advisors' Most Weighted Trades in Q2 2015 Jul 10 2015 
    Intrexon Corp is expanding his business Jun 25 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Abbvie Inc. Dividend Stock Analysis May 26 2015 
    Endo International Acquires Par Pharmaceuticals For $8 Billion May 21 2015 
    Risk & Reward with Gilead Sciences Inc. (GILD) May 14 2015 

    More From Other Websites
    Bargains Beckon as U.S. Stocks Bottom Aug 28 2015
    FDA warns of severe joint pain risk with DPP-4 diabetes drugs Aug 28 2015
    Credit Suisse's 8 Pharmaceutical Stocks With 'Significant' Upside Aug 28 2015
    The Zacks Analyst Blog Highlights: Merck & Co, Apple, Visa, Microsoft and Intel Aug 28 2015
    Merck in Indien Aug 28 2015
    Merck: A Great Dividend Stock for Retirees Aug 27 2015
    Merck Places Euro Bonds Amounting to € 2.1 Billion Aug 27 2015
    5 Stocks That Led Dow to 3rd Biggest Gain Aug 27 2015
    Merck Accelerator Program Participants Selected Aug 27 2015
    Ablynx burns more cash in first half of 2015 Aug 27 2015
    Is the bounce back real? Aug 26 2015
    Is the bounce back real? Aug 26 2015
    50 Beaten-Down Stocks For Your Buying Pleasure Aug 26 2015
    Short Sellers Have Mixed Feelings on Major Pharma Aug 26 2015
    Merck sues Taiwan company over generic antibiotic product Aug 25 2015
    Dow, S&P close lower in biggest reversal since Oct. 08 Aug 25 2015
    Biggest moves off the low Aug 24 2015
    The science that may help Jimmy Carter Aug 21 2015
    4 Defensive Stocks Acting as a Buffer Against the Market Sell-Off Aug 21 2015
    Jimmy Carter, Melanoma And The Promise Of Immunotherapy In The Elderly Aug 21 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK